(4-traders.com) 20 Apr, 2015 Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), an innovative company specializing in the development of orphan oncology drugs, today announced that preclinical and clinical data on belinostat will be presented at the 2015 American Association for Cancer Research (AACR) Annual Meeting (April 18-22, 2015)...http://www.4-traders.com/ONXEO-17068163/news/ONXEO--Belinostat-abstracts-for-American-Association-for-Cancer-Research-2015-ndash-Abstracts-om-20223591/